CANCER IMMUNOTHERAPY TODAY AND TOMORROW: 
A CONTINUING EDUCATION EVENT FOR CLINICIANS

Immune-based therapies have given physicians and patients powerful new tools to fight cancer, but they also present new challenges.

This course will address:

• Knowing when to administer immune therapy drugs and how
• Sequencing and combining treatments
• Managing toxicity and other immune related adverse events
• Keeping up with experimental approaches
• What to do when first-line immunotherapy fails
• Anticipating new immune therapies

KEYNOTE SPEAKERS

Dr. Edward Stadtmauer, Abramson Cancer Center at University of Pennsylvania
Dr. David Avigan, Cancer Center at Beth Israel Deaconess Medical Center 
Dr. David McDermott, Cancer Center at Beth Israel Deaconess Medical Center

For more information, click here.